Research ArticleWorkshops and Special Sessions
Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets
Sean R. Tunis, Lara J. Maxwell, Ian D. Graham, Beverley J. Shea, Dorcas E. Beaton, Clifton O. Bingham III, Peter Brooks, Philip G. Conaghan, Maria Antonietta D’Agostino, Maarten P. de Wit, Laure Gossec, Lyn M. March, Lee S. Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells and Peter Tugwell
The Journal of Rheumatology October 2017, 44 (10) 1551-1559; DOI: https://doi.org/10.3899/jrheum.161273
Sean R. Tunis
From the Center for Medical Technology Policy; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California,
USA; Centre for Practice-Changing Research, Ottawa Hospital Research Institute; Ottawa Hospital Research Institute, Clinical Epidemiology Program; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa; Cardiovascular Research Methods Centre, University of Ottawa Heart Institute; Department of Epidemiology and Community Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, University of Ottawa; Cochrane Musculoskeletal, University of Ottawa, Ottawa; Musculoskeletal Health and Outcomes Research, St. Michael’s Hospital; Institute for Work and Health; Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute and the Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario,
Canada; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne; Sydney Medical School, Institute of Bone and Joint Research and Department of Rheumatology, Royal North Shore Hospital, St. Leonards,
Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds,
UK; Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt; INSERM U1173, Laboratoire d’Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Montigny-le-Bretonneux; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris,
France; Department of Medical Humanities, VU University Medical Centre/EMGO+ Institute, Amsterdam,
the Netherlands.
Lara J. Maxwell
Ian D. Graham
Beverley J. Shea
Dorcas E. Beaton
Clifton O. Bingham III
Peter Brooks
Philip G. Conaghan
Maria Antonietta D’Agostino
Maarten P. de Wit
Laure Gossec
Lyn M. March
Lee S. Simon
Jasvinder A. Singh
Vibeke Strand
George A. Wells
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Straus SE,
- Tetroe J,
- Graham ID
- Straus SE,
- Tetroe J,
- Graham ID
- 4.↵
- Straus SE,
- Tetroe J,
- Graham ID
- Bowen S,
- Graham ID
- 5.↵
- Rycroft-Malone J,
- Burton CR,
- Bucknall T,
- Graham ID,
- Hutchinson AM,
- Stacey D
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- Rader T,
- Pardo Pardo J,
- Stacey D,
- Ghogomu E,
- Maxwell LJ,
- Welch VA,
- et al;
- Cochrane Musculoskeletal Group Editors
- 10.↵
- 11.↵
- 12.↵
- Kirkham JJ,
- Clarke M,
- Williamson PR
- 13.↵
- Bartlett SJ,
- Bykerk VP,
- Cooksey R,
- Choy EH,
- Alten R,
- Christensen R,
- et al.
- 14.↵
- Beaton DE,
- Dyer S,
- Boonen A,
- Verstappen SM,
- Escorpizo R,
- Lacaille DV,
- et al.
- 15.↵
- Kirwan JR,
- Hewlett SE,
- Heiberg T,
- Hughes RA,
- Carr M,
- Hehir M,
- et al.
- 16.↵
- Kirwan JR,
- Minnock P,
- Adebajo A,
- Bresnihan B,
- Choy E,
- de Wit M,
- et al.
- 17.↵
- de Wit M,
- Kirwan JR,
- Tugwell P,
- Beaton D,
- Boers M,
- Brooks P,
- et al.
- 18.↵
- de Wit M,
- Abma T,
- Koelewijn-van Loon M,
- Collins S,
- Kirwan J
- 19.↵
- de Wit MP,
- Abma TA,
- Koelewijn-van Loon MS,
- Collins S,
- Kirwan J
- 20.↵
- de Wit M,
- Abma T,
- Koelewijn-Van Loon M,
- Collins S,
- Kirwan J
- 21.↵
- 22.↵
- 23.↵
- Grol R,
- Dalhuijsen J,
- Thomas S,
- Veld C,
- Rutten G,
- Mokkink H
- 24.↵
- Rogers EM
- 25.↵
- 26.↵
- Tunis SR,
- Clarke M,
- Gorst SL,
- Gargon E,
- Blazeby JM,
- Altman DG,
- et al.
- 27.↵
- Cheung PP,
- de Wit M,
- Bingham CO 3rd,
- Kirwan JR,
- Leong A,
- March LM,
- et al.
- 28.↵
- Center for Medical Technology Policy (CMTP)
In this issue
The Journal of Rheumatology
Vol. 44, Issue 10
1 Oct 2017
Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets
Sean R. Tunis, Lara J. Maxwell, Ian D. Graham, Beverley J. Shea, Dorcas E. Beaton, Clifton O. Bingham, Peter Brooks, Philip G. Conaghan, Maria Antonietta D’Agostino, Maarten P. de Wit, Laure Gossec, Lyn M. March, Lee S. Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells, Peter Tugwell
The Journal of Rheumatology Oct 2017, 44 (10) 1551-1559; DOI: 10.3899/jrheum.161273
Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets
Sean R. Tunis, Lara J. Maxwell, Ian D. Graham, Beverley J. Shea, Dorcas E. Beaton, Clifton O. Bingham, Peter Brooks, Philip G. Conaghan, Maria Antonietta D’Agostino, Maarten P. de Wit, Laure Gossec, Lyn M. March, Lee S. Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells, Peter Tugwell
The Journal of Rheumatology Oct 2017, 44 (10) 1551-1559; DOI: 10.3899/jrheum.161273